RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ProMIS Neurosciences Stock

ProMIS Neurosciences Employees 2024

ProMIS Neurosciences Employees

1

Ticker

PMN.TO

ISIN

CA74346M1095

WKN

A14WN0

In 2024, ProMIS Neurosciences employed 1 people, a 0% change from the 1 number of employees in the previous year.

ProMIS Neurosciences Aktienanalyse

What does ProMIS Neurosciences do?

ProMIS Neurosciences Inc is a biopharmaceutical company based in Canada that specializes in the discovery and development of novel therapeutics for neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. The company was founded in 2004 and has been listed on the Toronto Stock Exchange since 2015. The goal of ProMIS is to develop highly specific therapeutics that specifically target the cellular causes of neurodegenerative diseases and can therefore stop or even reverse the progression of the disease. The company utilizes its proprietary platform technology to identify the unique epitopes on the pathological proteins that are specific to neurodegenerative diseases. ProMIS' business model is based on partnerships with large pharmaceutical companies that are searching for new therapeutics for neurodegenerative diseases. ProMIS works closely with these partners to develop customized therapeutics tailored to each partner's specific needs. The company licenses its technology and products to its partners and receives license and milestone payments when certain development or sales goals are achieved. ProMIS has different divisions to focus on various neurodegenerative diseases, with a focus on Alzheimer's, Parkinson's, and ALS. ProMIS has a comprehensive research and development infrastructure that focuses on the identification, characterization, and optimization of therapeutic antibodies and biomarkers. In terms of products, ProMIS has developed various antibodies that specifically target pathological proteins such as Aß and Tau in Alzheimer's and alpha-synuclein in Parkinson's. These antibodies can selectively recognize and bind to these pathological proteins, allowing them to be broken down and removed from the body. ProMIS works closely with its partners to test these antibodies in clinical trials and eventually bring them to market. In addition to its antibody products, ProMIS has also developed neuromethods that allow researchers to characterize and quantify the functions of proteins in brain cells and in vivo. These methods can be used to test and optimize the effects of antibodies and other therapeutics, making them an important part of ProMIS' development infrastructure. Overall, ProMIS Neurosciences Inc is an innovative biopharmaceutical company that focuses on the development of highly specific therapeutics for neurodegenerative diseases. The company has a comprehensive infrastructure and technology platform that allows it to develop customized products for its partners. With its antibodies and neuromethods, ProMIS has the potential to make a breakthrough in the treatment of neurodegenerative diseases and improve the lives of millions of patients. ProMIS Neurosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining ProMIS Neurosciences's Employee Base

ProMIS Neurosciences's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding ProMIS Neurosciences's operational capacity and future potential.

Year-to-Year Comparison

Assessing ProMIS Neurosciences's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

ProMIS Neurosciences's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in ProMIS Neurosciences’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about ProMIS Neurosciences stock

How many employees does ProMIS Neurosciences have this year?

ProMIS Neurosciences has 1 undefined employees this year.

How many employees did ProMIS Neurosciences have compared to the previous year?

Compared to the previous year, ProMIS Neurosciences had 0% more employees.

What impact did the number of employees have on the company ProMIS Neurosciences?

The number of employees has a direct impact on the efficiency and productivity of ProMIS Neurosciences. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of ProMIS Neurosciences?

The number of employees can also have an impact on investors of ProMIS Neurosciences, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of ProMIS Neurosciences affect the company?

An increase in equity of ProMIS Neurosciences can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in ProMIS Neurosciences's equity affect the company?

A reduction in equity of ProMIS Neurosciences can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of ProMIS Neurosciences?

Some factors that can influence the equity of ProMIS Neurosciences include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of ProMIS Neurosciences so important for investors?

The equity of ProMIS Neurosciences is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at ProMIS Neurosciences influence the company?

The number of employees at ProMIS Neurosciences can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at ProMIS Neurosciences evolved in recent years?

In recent years, the number of employees at ProMIS Neurosciences has changed by 0.

How many employees does ProMIS Neurosciences currently have?

ProMIS Neurosciences currently has 1 undefined employees.

Why is the number of employees important for investors of ProMIS Neurosciences?

The number of employees is important for investors of ProMIS Neurosciences as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can ProMIS Neurosciences take to change the number of employees?

To change the number of employees, ProMIS Neurosciences can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does ProMIS Neurosciences pay?

Over the past 12 months, ProMIS Neurosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ProMIS Neurosciences is expected to pay a dividend of 0 CAD.

What is the dividend yield of ProMIS Neurosciences?

The current dividend yield of ProMIS Neurosciences is .

When does ProMIS Neurosciences pay dividends?

ProMIS Neurosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ProMIS Neurosciences?

ProMIS Neurosciences paid dividends every year for the past 0 years.

What is the dividend of ProMIS Neurosciences?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ProMIS Neurosciences located?

ProMIS Neurosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von ProMIS Neurosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ProMIS Neurosciences from 11/5/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.

When did ProMIS Neurosciences pay the last dividend?

The last dividend was paid out on 11/5/2024.

What was the dividend of ProMIS Neurosciences in the year 2023?

In the year 2023, ProMIS Neurosciences distributed 0 CAD as dividends.

In which currency does ProMIS Neurosciences pay out the dividend?

The dividends of ProMIS Neurosciences are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The ProMIS Neurosciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von ProMIS Neurosciences

Our stock analysis for ProMIS Neurosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ProMIS Neurosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.